Evidence map›Paper›PMID 21228563›Full record

ReviewJournal of innate immunity2011

Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity?

Praveen Akuthota, Jason J Xenakis, Peter F Weller

Abstract readReview
In one paragraph

Review in Journal of innate immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Asthma, Sinonasal Disease, and the Risk of Active Tuberculosis.The journal of allergy and clinical immunology. In practice · 2019
    Article
  5. Regulatory effects of IL-15 on allergen-induced airway obstruction.The Journal of allergy and clinical immunology · 2018
    Article
  6. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Immunology and allergy clinics of North America · 2016
    Review
  7. Spectrum of Eosinophilic End-Organ Manifestations.Immunology and allergy clinics of North America · 2015
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Anti-IL-5 attenuates activation and surface density of β(2) -integrins on circulating eosinophils after segmental antigen challenge.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2013
    Article
  14. Eosinophilic inflammation in allergic asthma.Frontiers in pharmacology · 2013
    Article
  15. Review
  16. Eosinophils and disease pathogenesis.Seminars in hematology · 2012
    Review
  17. Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma.American journal of respiratory and critical care medicine · 2012
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Praveen AkuthotaDivision of a Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Jason J Xenakis
Peter F Weller

Funding

Human Eosinophils: Mechanisms of FunctioningR37AI020241 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLER, PETER F · 2010 to 2019
$4.5M
Airways Eosinophils as Antigen-presenting Cells in AsthmaR01AI051645 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLER, PETER F · 2001 to 2011
$3.8M
HUMAN EOSINOPHILS: MECHANISMS OF FUNCTIONINGR01AI020241 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WELLER, PETER F · 1985 to 2009
$3.5M
Tetraspanins in Asthma and Eosinophilic Lung DiseaseF32AI081513 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI AKUTHOTA, PRAVEEN · 2009 to 2010
$119k
NIAID NIH HHS AI020241NIAID NIH HHS AI051645NIAID NIH HHS F32 AI081513NIAID NIH HHS R01 AI020241NIAID NIH HHS R01 AI051645NIAID NIH HHS R37 AI020241
6 · The paper itself

Abstract

Eosinophils have long been noted to be present in asthma and other forms of pulmonary inflammation, but whether they act as true offenders or merely as bystanders has been a point of uncertainty. However, in recent years, there has been increasing evidence suggesting that eosinophils are not passive cells in the respiratory system, acting only as markers of allergic inflammation. This review discusses key evidence from animal models and human clinical trials that support the importance of eosinophils as active and necessary, rather than passive and unnecessary, to the pathogenesis of allergic airway disease. Analyses that are supportive of important immunoregulatory roles of eosinophils in allergic pulmonary inflammation are also reviewed. Data indicating that eosinophils contribute to viral, bacterial, and mycobacterial defense and clearance are detailed. Continually increasing evidence has supported a new conception of eosinophils as being multifaceted immune cells with complex interactions with other immune cells and their local environment.

Indexed as

AnimalsAsthmaDisease Models, AnimalEosinophilsHumansLungMiceRespiratory HypersensitivityRespiratory System

Identifiers

PMID21228563
PMCPMC3072201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.